reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 14 Sponsors

Enrolled Mar 3, 2026 · 37 words Open full page ↗

We're sorry but South Dakota Legislature Website doesn't work properly without JavaScript enabled. Please enable it to continue.

Your browser is not supported

Please update your browser or download one of the following browsers:

Chrome

Firefox

Edge

The document summary and details above are public. The full text is available to signed-in accounts.